Two Sigma Investments
IOBT

Two Sigma Investments’s IO Biotech IOBT Stock Holding History

Two Sigma Investments’s Portfolio IOBT Stock Details IOBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-30,000
Closed -$31.5K – 3341
2024
Q3 		$31.5K Buy
+30,000
New +$37.8K ﹤0.01% 2997

Other funds holding IOBT

VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.54B AUM 30.95% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Two Sigma Investments's IOBT Position: Q4 2024 in Review

Two Sigma Investments sold out of IO Biotech (IOBT) in Q4 2024, closing a stake of 30,000 shares — an estimated $31.5K sold.

Two Sigma Investments first reported a position in IOBT in Q3 2024 and held it in 1 quarter. The position peaked at $31.5K in Q3 2024. 27 funds tracked by Wall St. Rank hold IOBT as of Q4 2024.

  • Two Sigma Investments reported no remaining IO Biotech position as of Q4 2024 after selling out during the quarter.
  • Two Sigma Investments sold 30,000 IO Biotech shares in Q4 2024, an estimated $31.5K.
  • Two Sigma Investments first reported a position in IO Biotech in Q3 2024 and held it in 1 quarter.
  • Two Sigma Investments's IO Biotech position peaked at $31.5K in Q3 2024.
  • 27 funds tracked by Wall St. Rank held IO Biotech as of Q4 2024.

Based on Two Sigma Investments's 13F filing for Q4 2024, filed 14 Feb 2025.